Covance

Covance-Lilly Deal Continues to Bloom

Monday, March 15, 2010 06:51 AM

A little more than a year after Covance entered into a ground-breaking $1.6-billion drug development agreement with Eli Lilly, the contract research organization (CRO) continues to reap the awards of that deal and recently expanded the relationship.

More... »

Covance Revenue Up 8% in ‘09, Plans for 10% Growth in ‘10

Thursday, January 28, 2010 02:55 PM

Covance reported fourth-quarter revenue growth of 11% to $507 million, largely due to the positive impact of foreign exchange.

More... »

Unimed CRO Retools Name, Management

Friday, January 22, 2010 12:25 PM

Unimed, a contract research organization (CRO) in Prague, announced a name change and new management, following the final integration of its operations throughout Central and Eastern Europe.  The newly branded CRO—EastHORN—will continue to offer phase I to phase IV clinical trial services throughout the CEE region but plans to expand its reach to other countries within the region and perhaps as far as China and Africa in the future. The company has offices in Prague and Warsaw, as well as newly established offices in Bulgaria and Romania.

More... »

Lindevall Returns as CEO of Encorium

Friday, January 15, 2010 06:44 AM

CEO musical chairs continues at Wayne, Pa.-based contract research organization (CRO) Encorium . The company has reappointed Dr. Kai Lindevall as CEO, replacing David Ginsberg who left the company last summer when Encorium sold its U.S. business to Pierrel Research USA and Ginsberg became CEO there. Ginsberg had replaced Lindevall as CEO in September 2008. Lindevall, who replaced Kenneth Borow, M.D., as CEO in February 2008, has served as executive chairman since Ginsberg became CEO. Board member Shahab Fatheazam will serve as Encorium’s new chairman.  

More... »

Covance Opens Offices in Seoul, Mumbai

Thursday, December 17, 2009 07:42 AM

Covance recently opened new clinical development offices in Seoul, South Korea, and Mumbai, India, building on the contract research organization’s (CRO) two-decade history in the Asia-Pacific region.

More... »

Covance to Expand Food Safety Services with New Lab, Kellogg Contract

Monday, December 14, 2009 06:14 AM

Covance plans to invest $14 million in a nutritional chemistry and food safety laboratory in Michigan as part of an effort to expand the contract research organization’s (CRO’s) food safety testing capabilities. The CRO also entered into a seven-year, $42-million contract with Kellogg Company, which will be an anchor client to Covance’s new facility.

More... »

Phase Forward Q3 Revenues Jump 24%, Earnings Down by Half

Friday, October 30, 2009 09:11 AM

Waltham, Mass-based Phase Forward, a provider of data management solutions for clinical trials and drug safety, reported third quarter revenues jumped 24% to $53.1 million, compared with the third quarter of 2008, but earnings were cut in half.

More... »

Covance 3Q Revenue Up, Operating Income Down

Thursday, October 22, 2009 07:16 AM

Covance, a global contract research organization, reported third quarter revenues grew 8% to $493.7 million compared with the prior year quarter, but operating income slipped 17% to $57.8 million.

More... »

Covance Opens New Offices in Brazil and Mexico

Friday, September 25, 2009 09:36 AM

Covance opened new clinical development offices in Sao Paolo, Brazil, and Mexico City, Mexico to further expand the contract research organization’s (CRO’s) services in Latin America and increase access to patients, the company said.

More... »

Covance Expands Sleep Study Expertise

Friday, September 4, 2009 11:14 AM

Covance is expanding its capacity to support specialized sleep studies through a collaboration with Sleep Medicine Associates. 

More... »